• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者中心静脉闭塞再通的结局及成功预测因素:一项回顾性研究

Outcome of Central Vein Occlusion Recanalization in Hemodialysis Patients and Predictors for Success: A Retrospective Study.

作者信息

Hongsakul Keerati, Leelarujijaroen Pattarasuda, Boonsrirat Ussanee

机构信息

Prince of Songkla University, TH.

出版信息

J Belg Soc Radiol. 2020 May 6;104(1):20. doi: 10.5334/jbsr.1991.

DOI:10.5334/jbsr.1991
PMID:32405611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7207257/
Abstract

BACKGROUND

Catheter-directed treatment is the standard approach for the management of chronic central venous occlusion.

PURPOSE

The objective of this study is to report the outcome of conventional recanalization of chronic central vein occlusion in hemodialysis patients and to determine the predictors for success.

MATERIAL AND METHODS

All hemodialysis patients who underwent endovascular recanalization of central vein occlusion from January 2012 to December 2016 were retrospectively evaluated. The procedure was percutaneous transluminal angioplasty. Stenting was performed in case of a significant recoil stenosis. Kaplan-Meier analysis was used to evaluate central vein patency. Univariate analysis and multivariate logistic regression were used to calculate the predictive factors.

RESULTS

Ninety-seven patients (mean age, 61.2 years; range, 25‒89 years old) with 97 central vein occlusions were enrolled. Technical success was achieved in 49 patients (50.5%). The primary patency rates of central veins at 6 and 12 months were achieved in 17 patients (34.4%) and 8 patients (15.8%), respectively. The assisted primary patency rates at 6 and 12 months were achieved in 38 patients (77.3%) and 30 patients (61%), respectively. Patient age ≥60 years and a tapered-type of lesion were significant predictive factors for successful recanalization.

CONCLUSION

Endovascular treatment of the central vein occlusion using a conventional technique is moderately effective and safe. Angioplasty alone and stenting were not significantly different in terms of patency rate. The age of the patients and type of occlusion were significant predictors for successful recanalization.

摘要

背景

导管定向治疗是慢性中心静脉闭塞管理的标准方法。

目的

本研究的目的是报告血液透析患者慢性中心静脉闭塞传统再通的结果,并确定成功的预测因素。

材料与方法

回顾性评估2012年1月至2016年12月期间接受中心静脉闭塞血管腔内再通的所有血液透析患者。该手术为经皮腔内血管成形术。出现明显回缩性狭窄时进行支架置入。采用Kaplan-Meier分析评估中心静脉通畅情况。单因素分析和多因素逻辑回归用于计算预测因素。

结果

纳入97例中心静脉闭塞的患者(平均年龄61.2岁;范围25 - 89岁)。49例患者(50.5%)获得技术成功。中心静脉6个月和12个月的初级通畅率分别为17例患者(34.4%)和8例患者(15.8%)。6个月和12个月的辅助初级通畅率分别为38例患者(77.3%)和30例患者(61%)。患者年龄≥60岁和病变呈锥形是成功再通的重要预测因素。

结论

采用传统技术对中心静脉闭塞进行血管腔内治疗具有中等疗效且安全。单纯血管成形术和支架置入术在通畅率方面无显著差异。患者年龄和闭塞类型是成功再通的重要预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/ddfc76d79f92/jbsr-104-1-1991-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/4673e5caf1b2/jbsr-104-1-1991-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/e4b982c99032/jbsr-104-1-1991-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/85b476336697/jbsr-104-1-1991-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/ddfc76d79f92/jbsr-104-1-1991-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/4673e5caf1b2/jbsr-104-1-1991-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/e4b982c99032/jbsr-104-1-1991-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/85b476336697/jbsr-104-1-1991-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ab/7207257/ddfc76d79f92/jbsr-104-1-1991-g4.jpg

相似文献

1
Outcome of Central Vein Occlusion Recanalization in Hemodialysis Patients and Predictors for Success: A Retrospective Study.血液透析患者中心静脉闭塞再通的结局及成功预测因素:一项回顾性研究
J Belg Soc Radiol. 2020 May 6;104(1):20. doi: 10.5334/jbsr.1991.
2
Efficacy and safety of recanalization with transseptal needle for chronic total occlusion of the brachiocephalic vein in hemodialysis patients.经房间隔穿刺针再通术治疗血液透析患者头臂静脉慢性完全闭塞的疗效与安全性
Ann Transl Med. 2020 Sep;8(18):1141. doi: 10.21037/atm-20-5369.
3
Sharp recanalization with transseptal needle for unsuccessful standard recanalization of chronic thoracic central vein occlusion in hemodialysis patients.经间隔穿刺针锐性再通用于血液透析患者慢性胸廓内中央静脉闭塞标准再通失败的情况。
J Vasc Access. 2025 Jul;26(4):1310-1317. doi: 10.1177/11297298241278007. Epub 2024 Sep 5.
4
Characteristics and outcomes of stent occlusion after iliocaval stenting.髂静脉支架置入术后支架闭塞的特点和结局。
J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):56-64. doi: 10.1016/j.jvsv.2018.07.013. Epub 2018 Nov 12.
5
Central venous occlusion in hemodialysis access: Comparison between percutaneous transluminal angioplasty alone and nitinol or stainless-steel stent placement.血液透析通路中的中心静脉阻塞:单纯经皮腔内血管成形术与镍钛诺或不锈钢支架置入的比较。
Diagn Interv Imaging. 2019 Sep;100(9):485-492. doi: 10.1016/j.diii.2019.03.011. Epub 2019 Apr 2.
6
Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.血液透析患者中心静脉狭窄的初次血管成形术和初次支架置入术的长期预后。
J Vasc Surg. 2007 Apr;45(4):776-83. doi: 10.1016/j.jvs.2006.12.046.
7
The outcome of sharp recanalization of chronic central venous occlusions in patients undergoing hemodialysis.血液透析患者慢性中心静脉闭塞的急性再通治疗结果。
J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101692. doi: 10.1016/j.jvsv.2023.09.006. Epub 2023 Oct 4.
8
Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-analysis.经皮腔内血管成形术与支架置入治疗血液透析患者中心静脉狭窄或闭塞的比较:系统评价和荟萃分析。
Cardiovasc Intervent Radiol. 2020 Apr;43(4):525-540. doi: 10.1007/s00270-019-02383-7. Epub 2020 Jan 3.
9
Endovascular recanalization for nonmalignant obstruction of the inferior vena cava.血管内再通治疗下腔静脉非恶性梗阻。
J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):173-182. doi: 10.1016/j.jvsv.2017.10.017. Epub 2018 Jan 11.
10
Percutaneous intervention for symptomatic central vein stenosis in patients with upper limb arteriovenous dialysis access.上肢动静脉透析通路患者症状性中心静脉狭窄的经皮介入治疗
Indian Heart J. 2018 Sep-Oct;70(5):690-698. doi: 10.1016/j.ihj.2018.01.013. Epub 2018 Jan 10.

引用本文的文献

1
Factors Affecting Outcomes of Percutaneous Transluminal Angioplasty for Central Vein Occlusive Disease in the University of the Philippines-Philippine General Hospital: A 10-Year Experience.菲律宾大学-菲律宾总医院中心静脉闭塞性疾病经皮腔内血管成形术治疗结果的影响因素:十年经验
Acta Med Philipp. 2024 Nov 29;58(21):40-48. doi: 10.47895/amp.vi0.8542. eCollection 2024.
2
The evolving panorama of vascular access in the 21st century.21世纪血管通路的发展全景。
Front Nephrol. 2022 Oct 26;2:917265. doi: 10.3389/fneph.2022.917265. eCollection 2022.
3
Thoracic central venous occlusion from the interventional radiology perspective.

本文引用的文献

1
Paclitaxel-Coated Balloon Angioplasty for Early Restenosis of Central Veins in Hemodialysis Patients: A Single Center Initial Experience.紫杉醇涂层球囊血管成形术治疗血液透析患者中心静脉早期再狭窄:单中心初步经验。
Korean J Radiol. 2018 May-Jun;19(3):410-416. doi: 10.3348/kjr.2018.19.3.410. Epub 2018 Apr 6.
2
Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial.用于治疗透析通路中症状性中心静脉狭窄的紫杉醇涂层球囊:一项随机对照试验的结果
J Vasc Interv Radiol. 2017 Jun;28(6):811-817. doi: 10.1016/j.jvir.2017.03.007. Epub 2017 Apr 20.
3
从介入放射学角度看胸段中心静脉闭塞
Cardiovasc Diagn Ther. 2023 Feb 28;13(1):299-310. doi: 10.21037/cdt-22-93. Epub 2022 Jun 23.
4
The efficacy and safety of blunt impingement followed by a sharp recanalization technique in hemodialysis patients with refractory central vein occlusion: a single-center experience.钝性撞击联合锐性再通技术在难治性中心静脉闭塞血液透析患者中的疗效与安全性:单中心经验
Ann Transl Med. 2022 Jul;10(14):768. doi: 10.21037/atm-22-3131.
5
Clinical Implications of Phenotypes of Hemodialysis Patients With Central Venous Occlusion or Central Venous Stenosis Defined by Cluster Analysis.通过聚类分析定义的中心静脉闭塞或中心静脉狭窄的血液透析患者表型的临床意义
Front Cardiovasc Med. 2022 Jun 20;9:901237. doi: 10.3389/fcvm.2022.901237. eCollection 2022.
Endovascular interventions for central vein stenosis.
血管内介入治疗中心静脉狭窄。
Kidney Res Clin Pract. 2015 Dec;34(4):228-32. doi: 10.1016/j.krcp.2015.10.005. Epub 2015 Nov 12.
4
Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas.紫杉醇涂层球囊血管成形术治疗血液透析动静脉内瘘有症状的中心静脉再狭窄
J Endovasc Ther. 2015 Feb;22(1):74-9. doi: 10.1177/1526602814566907.
5
Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques.用于治疗常规血管内技术失败的中心静脉阻塞的射频导丝。
J Vasc Interv Radiol. 2012 Aug;23(8):1016-21. doi: 10.1016/j.jvir.2012.05.049. Epub 2012 Jun 26.
6
Long-term results of stent-graft placement to treat central venous stenosis and occlusion in hemodialysis patients with arteriovenous fistulas.支架置入治疗血液透析患者动静脉瘘中心静脉狭窄和闭塞的长期结果。
J Vasc Interv Radiol. 2011 Sep;22(9):1240-5. doi: 10.1016/j.jvir.2011.06.002. Epub 2011 Jul 20.
7
Central venous obstruction management.中心静脉阻塞的管理。
Semin Intervent Radiol. 2009 Jun;26(2):115-21. doi: 10.1055/s-0029-1222454.
8
Review of central venous disease in hemodialysis patients.血液透析患者中心静脉疾病的综述。
J Vasc Interv Radiol. 2010 Jul;21(7):963-8. doi: 10.1016/j.jvir.2010.01.044. Epub 2010 Apr 24.
9
Use of a rosch-uchida needle for recanalization of refractory dialysis-related central vein occlusion.使用罗氏乌奇达针进行难治性透析相关中心静脉闭塞再通。
AJR Am J Roentgenol. 2010 May;194(5):1352-6. doi: 10.2214/AJR.09.3485.
10
Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience.126 例血液透析患者中心静脉阻塞经血管成形术和支架置入治疗的 10 年单中心经验:长期结果。
AJR Am J Roentgenol. 2009 Dec;193(6):1672-9. doi: 10.2214/AJR.09.2654.